GRDX — GridAI Technologies Share News
0.000.00%
Last trade - 00:00- $39.97m
- $45.06m
- $0.04m
First Wave BioPharma Inc expected to post a loss of $2.43 a share - Earnings Preview
Brief: First Wave Biopharma To Raise Approximately $1.1 Million Of Gross Proceeds Priced At-The-Market
First Wave BioPharma Inc reports results for the quarter ended in December - Earnings Summary
First Wave BioPharma Inc expected to post a loss of $4.03 a share - Earnings Preview
First Wave BioPharma Inc expected to post a loss of $4.66 a share - Earnings Preview
First Wave BioPharma Inc expected to post a loss of $4.66 a share - Earnings Preview
Brief: First Wave Biopharma Announces Completion Of Business Combination With Immunogenx
Brief: First Wave BioPharma To Raise About $4 Mln In Registered Direct Offering
Brief: First Wave BioPharma Says Initiation Of Phase 3 Trials For Latiglutenase Expected in H2 2024
Newscasts - Wall St ticks up, S&P 500 near all-time closing high
U.S. STOCKS ON THE MOVE-First Solar, Fusion Pharmaceuticals, MicroStrategy
Brief: First Wave Biopharma Announces Issuance Of New Warrants In A Private Placement
Newscasts - Trading at Noon: S&P 500 closes in on its all-time high
U.S. STOCKS ON THE MOVE-Tesla, Gold miners, Weyerhaeuser
U.S. STOCKS ON THE MOVE-Reneo Pharma, Cytokinetics, Burford Capital
U.S. STOCKS ON THE MOVE-Bit Digital, First Wave BioPharma, Cingulate
First Wave BioPharma surges after selling bowel disease drug
Brief: First Wave Biopharma Announces Streamlining Of Clinical Pipeline With Non-Binding Term Sheet To Sell Niclosamide Ibd Program
Brief: First Wave BioPharma Enters into Term Sheet for Business Combination with ImmunogenX